Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers

Purpose: To demonstrate the safety and feasibility of leveraging therapeutic antibodies for surgical imaging. Procedures: We conducted two phase I trials for anti-epidermal growth factor receptor antibodies cetuximab-IRDye800CW (n=12) and panitumumab-IRDye800CW (n=15). Adults with biopsy-confirmed h...

全面介紹

Na minha lista:
書目詳細資料
發表在:Theranostics
Main Authors: Gao, Rebecca W., Teraphongphom, Nutte, de Boer, Esther, van den Berg, Nynke S., Divi, Vasu, Kaplan, Michael J., Oberhelman, Nicholas J., Hong, Steven S., Capes, Elissa, Colevas, A. Dimitrios, Warram, Jason M., Rosenthal, Eben L.
格式: Artigo
語言:Inglês
出版: Ivyspring International Publisher 2018
主題:
Research Paper
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5928904/
https://ncbi.nlm.nih.gov/pubmed/29721094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.24487
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍